ALECP Fundamental Analysis - EUROPACORP

Name: EUROPACORP (ALECP) Stock
Brand: EUROPACORP
Rating: 4 (3 reviews)

Fundamental Rating

Overall ALECP gets a fundamental rating of 2 out of 10. We evaluated ALECP against 46 industry peers in the Entertainment industry. Both the profitability and financial health of ALECP have multiple concerns. ALECP has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALECP has reported negative net income.

In the past year ALECP had a positive cash flow from operations.

Of the past 5 years ALECP 4 years were profitable.

ALECP had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.61%, ALECP is doing worse than 60.87% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-4.61%
ROE	N/A
ROIC	N/A

ROA(3y)-1.27%

ROA(5y)19.21%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALECP's Gross Margin of 13.83% is on the low side compared to the rest of the industry. ALECP is outperformed by 93.48% of its industry peers.

ALECP's Gross Margin has declined in the last couple of years.

ALECP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	13.83%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-36.32%

GM growth 5Y-14.72%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALECP does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALECP has more shares outstanding

ALECP has more shares outstanding than it did 5 years ago.

ALECP has about the same debt/assets ratio as last year.

2.2 Solvency

ALECP has an Altman-Z score of -1.76. This is a bad value and indicates that ALECP is not financially healthy and even has some risk of bankruptcy.

ALECP has a Altman-Z score of -1.76. This is amonst the worse of the industry: ALECP underperforms 84.78% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-1.76

ROIC/WACCN/A

WACC4.81%

2.3 Liquidity

ALECP has a Current Ratio of 1.37. This is a normal value and indicates that ALECP is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Current ratio value of 1.37, ALECP is doing good in the industry, outperforming 78.26% of the companies in the same industry.

A Quick Ratio of 1.37 indicates that ALECP should not have too much problems paying its short term obligations.

With a decent Quick ratio value of 1.37, ALECP is doing good in the industry, outperforming 78.26% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.37
Quick Ratio	1.37

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALECP have decreased strongly by -685.29% in the last year.

Looking at the last year, ALECP shows a very negative growth in Revenue. The Revenue has decreased by -10.64% in the last year.

The Revenue for ALECP have been decreasing by -14.67% on average. This is quite bad

EPS 1Y (TTM)-685.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-101.56%

Revenue 1Y (TTM)-10.64%

Revenue growth 3Y-3.65%

Revenue growth 5Y-14.67%

Sales Q2Q%-8.15%

3.2 Future

The Earnings Per Share is expected to decrease by -38.96% on average over the next years. This is quite bad

ALECP is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -35.46% yearly.

EPS Next Y-49.12%

EPS Next 2Y-38.96%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-53.15%

Revenue Next 2Y-35.46%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALECP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 6.35, the valuation of ALECP can be described as very cheap.

97.83% of the companies in the same industry are more expensive than ALECP, based on the Price/Forward Earnings ratio.

ALECP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 32.73.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	6.35

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALECP is valued a bit cheaper than 78.26% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	4.47

4.3 Compensation for Growth

A cheap valuation may be justified as ALECP's earnings are expected to decrease with -38.96% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-38.96%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALECP does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EUROPACORP

EPA:ALECP (11/7/2025, 7:00:00 PM)

0.396

-0.02 (-5.04%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryEntertainment

Earnings (Last)05-27 2025-05-27

Earnings (Next)12-09 2025-12-09

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners13.1%

Ins Owner ChangeN/A

Market Cap49.67M

Revenue(TTM)31.57M

Net Income(TTM)-4.94M

Analysts86.67

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	6.35
P/S	1.57
P/FCF	N/A
P/OCF	2.41
P/B	N/A
P/tB	N/A
EV/EBITDA	4.47

EPS(TTM)-0.04

EYN/A

EPS(NY)0.06

Fwd EY15.74%

FCF(TTM)-0.07

FCFYN/A

OCF(TTM)0.16

OCFY41.42%

SpS0.25

BVpS-0.02

TBVpS-0.33

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.61%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	13.83%
FCFM	N/A

ROA(3y)-1.27%

ROA(5y)19.21%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-36.32%

GM growth 5Y-14.72%

F-Score3

Asset Turnover0.29

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	3.18
Cap/Depr	135%
Cap/Sales	91.96%
Interest Coverage	N/A
Cash Conversion	113.68%
Profit Quality	N/A
Current Ratio	1.37
Quick Ratio	1.37
Altman-Z	-1.76

F-Score3

WACC4.81%

ROIC/WACCN/A

Cap/Depr(3y)110.61%

Cap/Depr(5y)70.32%

Cap/Sales(3y)61.29%

Cap/Sales(5y)38.43%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-685.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-101.56%

EPS Next Y-49.12%

EPS Next 2Y-38.96%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-10.64%

Revenue growth 3Y-3.65%

Revenue growth 5Y-14.67%

Sales Q2Q%-8.15%

Revenue Next Year-53.15%

Revenue Next 2Y-35.46%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-399.12%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-31.46%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-71.26%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y11.64%

OCF growth 3Y0.62%

OCF growth 5Y-7.81%

EUROPACORP / ALECP.PA FAQ

What is the fundamental rating for ALECP stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALECP.PA.

Can you provide the valuation status for EUROPACORP?

ChartMill assigns a valuation rating of 3 / 10 to EUROPACORP (ALECP.PA). This can be considered as Overvalued.

Can you provide the profitability details for EUROPACORP?

EUROPACORP (ALECP.PA) has a profitability rating of 2 / 10.

How financially healthy is EUROPACORP?

The financial health rating of EUROPACORP (ALECP.PA) is 2 / 10.

What is the earnings growth outlook for EUROPACORP?

The Earnings per Share (EPS) of EUROPACORP (ALECP.PA) is expected to decline by -49.12% in the next year.

EUROPACORP (ALECP.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EUROPACORP / ALECP.PA FAQ

What is the fundamental rating for ALECP stock?

Can you provide the valuation status for EUROPACORP?

Can you provide the profitability details for EUROPACORP?

How financially healthy is EUROPACORP?

What is the earnings growth outlook for EUROPACORP?